ArticleFrontiers in oncology2023

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).

Joseph Tintelnot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.